Expanded Access Study Amifampridine Phosphate in Congenital Myasthenic Syndrome (CMS)
An Open-Label, Expanded Access Protocol for Amifampridine Phosphate Treatment in Patients With Congenital Myasthenic Syndrome (CMS) An Open-Label, Expanded Access Protocol for AmifampridinePhosphate Treatment in Patients With Congen ...